Jhunjhunwala-Backed IKS Health Set for INR 400 Cr Block Trade
According to sources, around 1.5% of the company's outstanding equity is set to be traded, and it is also indicated that multiple individual investors will likely offload their shares during this transaction.
IKS Health, backed by the Jhunjhunwala family, is expected to witness a significant block deal valued at over INR 400 Cr.
According to sources, around 1.5% of the company's outstanding equity is set to be traded, and it is also indicated that multiple individual investors will likely offload their shares during this transaction.
The floor price for the block deal has been set at INR 1,650 per share, representing a 2.6% discount compared to Wednesday’s closing price of INR 1,695.
Based on this floor price and the total outstanding equity, the transaction is projected to exceed INR 400 Cr in value.
Promoter entities such as the Nistha Jhunjhunwala Discretionary Trust, Aryavir Jhunjhunwala Discretionary Trust, and Aryaman Jhunjhunwala Discretionary Trust each hold a 16.37% stake in IKS Health. Several other individual promoters are also listed as shareholders as of the March 2025 quarter.
Notably, this expected block deal comes immediately after the end of the six-month post-listing lock-in period, which concluded on Wednesday. As of that date, 10.5 Cr shares, worth nearly USD 20 billion, became eligible for trading.
IKS Health operates a comprehensive Care Enablement Platform that integrates AI-driven technology and human expertise to streamline administrative, clinical, and operational tasks across healthcare systems.
The platform supports over 853 clients, primarily in the US, with services including revenue cycle management, clinical documentation (including AI scribing), care team assistance, and value-based care coordination.
In another recent development related to IKS Health, the company’s initial public offering (IPO), which opened on December 12, 2024, was fully subscribed on the very first day of bidding.
Under the IPO structure, 75% of shares were reserved for QIBs, 15% for non-institutional investors (NIIs), and 10% for retail participants. An additional 65,000 shares were earmarked for employees.
The IPO closed on December 16, 2024. Share allotment was finalized on December 17, and the company was tentatively listed on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE) on December 19.
Stay tuned for more such updates on Digital Health News
